New Zealand Said To Rush Coverage Of Boehringer Ingelheim Drug
This article was originally published in PharmAsia News
Executive Summary
New Zealand's drug reimbursement agency, Pharmac, is being accused by some doctors of backing a Boehringer Ingelheim anti-blood clotting drug before side effects were fully tested